Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Treatment of Japanese patients with enteric fever using azithromycin and MIC levels for causative organisms.

Ohnishi K, Kobayashi K, Iwabuchi S, Nakamura-Uchiyama F.

Southeast Asian J Trop Med Public Health. 2013 Jan;44(1):109-13.

PMID:
23682445
2.

WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD006083. doi: 10.1002/14651858.CD006083.pub3. Review.

PMID:
21975751
3.

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006083. doi: 10.1002/14651858.CD006083.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD006083.

PMID:
18843701
4.

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).

Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD004530. doi: 10.1002/14651858.CD004530.pub4. Review.

PMID:
21975746
5.

Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance.

Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, Khakhria R.

Antimicrob Agents Chemother. 1999 Jun;43(6):1441-4.

6.

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, Tham NT, Wain J, Hien TT, Farrar JJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):819-25. Epub 2006 Dec 4.

7.

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ.

Antimicrob Agents Chemother. 2000 Jul;44(7):1855-9.

8.

Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A.

Kobayashi T, Hayakawa K, Mawatari M, Mezaki K, Takeshita N, Kutsuna S, Fujiya Y, Kanagawa S, Ohmagari N, Kato Y, Morita M.

BMC Infect Dis. 2014 Jul 20;14:404. doi: 10.1186/1471-2334-14-404.

9.

Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.

Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.

BMC Infect Dis. 2004 Sep 20;4:36.

10.

Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India.

Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, Potkar CN, Zelasky MT, Johnson RB.

J Antimicrob Chemother. 1999 Aug;44(2):243-50.

PMID:
10473232
11.

In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.

Capoor MR, Rawat D, Nair D, Hasan AS, Deb M, Aggarwal P, Pillai P.

J Med Microbiol. 2007 Nov;56(Pt 11):1490-4.

PMID:
17965350
12.
13.

Oral administration of fluoroquinolones in the treatment of typhoid fever and paratyphoid fever in Japan.

Ohnishi K, Kimura K, Masuda G, Tsunoda T, Obana M, Yoshida H, Goto T, Sakaue Y, Kim YK, Sakamoto M, Sagara H.

Intern Med. 2000 Dec;39(12):1044-8.

14.

Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents.

Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, Wierzba T, Morsy M, Knirsch C.

Clin Infect Dis. 2004 Apr 1;38(7):951-7. Epub 2004 Mar 12.

PMID:
15034826
15.
16.

Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.

Parry CM, Thieu NT, Dolecek C, Karkey A, Gupta R, Turner P, Dance D, Maude RR, Ha V, Tran CN, Thi PL, Be BP, Phi LT, Ngoc RN, Ghose A, Dongol S, Campbell JI, Thanh DP, Thanh TH, Moore CE, Sona S, Gaind R, Deb M, Anh HV, Van SN, Tinh HT, Day NP, Dondorp A, Thwaites G, Faiz MA, Phetsouvanh R, Newton P, Basnyat B, Farrar JJ, Baker S.

Antimicrob Agents Chemother. 2015 May;59(5):2756-64. doi: 10.1128/AAC.04729-14. Epub 2015 Mar 2. Erratum in: Antimicrob Agents Chemother. 2015 Jul;59(7):4364.

17.

A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.

Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, Doan CD, Nguyen TB, Duong TL, Luong BH, Nguyen TB, Nguyen TA, Pham ND, Mai NL, Phan VB, Vo AH, Nguyen VM, Tran TT, Tran TC, Schultsz C, Dunstan SJ, Stepniewska K, Campbell JI, To SD, Basnyat B, Nguyen VV, Nguyen VS, Nguyen TC, Tran TH, Farrar J.

PLoS One. 2008 May 21;3(5):e2188. doi: 10.1371/journal.pone.0002188.

18.

Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study.

Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh AO.

Indian Pediatr. 2011 Jul;48(7):553-6.

PMID:
21555791
19.

Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.

Unal S, Hayran M, Tuncer S, Gür D, Uzun O, Akova M, Akalin HE.

Antimicrob Agents Chemother. 1996 Dec;40(12):2898-900.

20.

Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.

Thisyakorn U, Mansuwan P, Taylor DN.

Am J Dis Child. 1987 Aug;141(8):862-5.

PMID:
3115088

Supplemental Content

Support Center